PureTech Health (PRTC) News Today → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free PRTC Stock Alerts GBX 223 +1.50 (+0.68%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePureTech Names Bharatt Chowrira CEO As Daphne Zohar Turns CEO Of Newly Launched Seaport Therapeuticsmarkets.businessinsider.com - April 9 at 3:41 AMHere’s one FTSE 250 stock I’d buy in Aprilmsn.com - April 2 at 6:26 AMPureTech Health plcthestreet.com - March 22 at 9:17 AMPureTech announces $100M capital return through tender offermsn.com - March 19 at 11:27 AMAKLI Mar 2024 1.000 callfinance.yahoo.com - February 28 at 3:30 PM2 impressive growth stocks I’ve got my eye on in Februarymsn.com - February 8 at 4:18 PMPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophreniafinance.yahoo.com - November 17 at 7:34 AMPureTech Health celebrates positive results in Phase 2 anxiety triallse.co.uk - November 14 at 8:40 AMPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteersfinance.yahoo.com - November 14 at 8:40 AMPureTech Health plc - Half-Year Reportfinanznachrichten.de - August 29 at 4:02 AMPureTech bags $11.4M from U.S. Department of Defense contractmsn.com - August 1 at 3:37 PMPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndromefinance.yahoo.com - August 1 at 7:43 AMPureTech Health launches next stage of anxiety disorder drug triallse.co.uk - June 21 at 8:54 AMPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disordersfinance.yahoo.com - June 21 at 8:54 AMPureTech Health Stock (NASDAQ:PRTC), Dividendsbenzinga.com - April 29 at 1:11 AMPureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The Detailsmarkets.businessinsider.com - April 28 at 10:02 AMMicrobiome-focused PureTech spinout raises $106.5M to fund two trialsbizjournals.com - April 25 at 8:57 AMPureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapiesfinance.yahoo.com - April 25 at 8:57 AMPureTech Health's Vedanta Biosciences boasts "promising" resultslse.co.uk - April 20 at 12:24 AMPureTech Health remains undervalued after KarXCT deal, says brokerproactiveinvestors.com - March 23 at 1:45 PMPureTech Health Shares Rise on Schizophrenia Treatment Candidate Royalty Dealmarketwatch.com - March 23 at 8:45 AMRoyalty Pharma Acquires Interest In PureTech's Royalty In Karuna Therapeutics' KarXTmarkets.businessinsider.com - March 23 at 8:45 AMPureTech Health shares jump 10% on US$500mln royalty dealproactiveinvestors.com - March 23 at 8:45 AMRoyalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Millionfinance.yahoo.com - March 23 at 8:45 AMPureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)finance.yahoo.com - February 27 at 5:40 PMPureTech Health's Depression Treatment Phase 1 Study Shows Positive Datamarketwatch.com - December 19 at 9:02 AMPureTech to Present at 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 13 at 7:53 AMPureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meetingfinance.yahoo.com - December 12 at 4:47 PMPureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoringfinance.yahoo.com - December 9 at 7:51 AMPureTech to Present at the Jefferies London Healthcare Conferencefinance.yahoo.com - November 9 at 8:54 AMPureTech Health confirms ‘possible combination’ with Nektar Therapeuticsproactiveinvestors.com - October 7 at 3:39 AMPureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticalsfinance.yahoo.com - August 24 at 11:54 AMCiting 'challenging economic environment,' Cambridge biotech cuts 20% of stafffinance.yahoo.com - August 11 at 3:31 PMPureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japanfinance.yahoo.com - August 1 at 7:13 AMPureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute "Long" COVID with Respiratory Complicationsfinance.yahoo.com - June 14 at 3:53 AMPureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300finance.yahoo.com - June 14 at 3:53 AMInvestors in PureTech Health (LON:PRTC) have unfortunately lost 52% over the last yearfinance.yahoo.com - May 23 at 4:49 AMPureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022finance.yahoo.com - May 16 at 12:22 PMPureTech Announces Share Buyback Program Updatefinance.yahoo.com - May 9 at 7:11 AMPureTech Announces Share Buyback Program of up to $50 Millionfinance.yahoo.com - May 5 at 2:18 AMPureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Resultsfinance.yahoo.com - April 13 at 12:41 PMPureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officerfinance.yahoo.com - March 17 at 12:51 PMWhat Percentage Of PureTech Health plc (LON:PRTC) Shares Do Insiders Own?finance.yahoo.com - March 1 at 4:18 AMPureTech Founded Entity Akili Announces PLOS ONE...benzinga.com - February 17 at 4:31 PMPureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Normsfinance.yahoo.com - January 31 at 9:07 AMPureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. Ifinance.yahoo.com - January 26 at 9:03 AMPalihapitiya-Led SPAC Said to Discuss Akili Interactive Dealfinance.yahoo.com - January 9 at 8:42 PMPureTech’s LYT-100 achieves 50% reduction in GI-related adverse events vs. pirfenidoneseekingalpha.com - January 6 at 8:10 AMPureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidonefinance.yahoo.com - January 6 at 3:09 AMInsiders who bought PureTech Health plc (LON:PRTC) stock in the last 12 months recover some losses, but still down US$21kfinance.yahoo.com - December 31 at 7:30 AM Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address 1970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans. Click here to watch his new video ASAP PRTC Media Mentions By Week PRTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTC News Sentiment▼0.000.36▲Average Medical News Sentiment PRTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTC Articles This Week▼00▲PRTC Articles Average Week Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ERGO News Today ONT News Today OXB News Today BVXP News Today HVO News Today ARIX News Today AVCT News Today GNS News Today CRW News Today AMS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:PRTC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.